PHYSICIANS The American Diabetes Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Diabetes Association designates this live activity for a maximum of 11.0 AMA PRA Category 1 credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity. DOCTORS OF OSTEOPATHY Category 2 credit will be awarded for formal educational programs that are ACCME-accredited or AAFP-approved. INTERNATIONAL PHYSICIANS The American Medical Association has determined that physicians not licensed in the US who participate in this CME activity are eligible for AMA PRA Category 1 credit. PHYSICIAN ASSISTANTS AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 11.0 hours of Category I credit for completing this program. PODIATRIC PHYSICIANS Affiliate sponsorship has been given by the American Podiatric Medical Association (APMA) for 11.0 hours of continuing medical education for this activity. NURSES The American Diabetes Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center s COA. CALIFORNIA BOARD OF REGISTERED NURSING The American Diabetes Association is also a provider approved by the California Board of Registered Nursing, Provider No. CEP-12196. This activity is approved for 11.0 contact hours. DIETITIANS The American Diabetes Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive11.0 continuing professional education units (CPEUs) for completion of this program/material. PHARMACISTS The American Diabetes Association is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. ACPE Provider number 0239. This knowledge-based activity provides 11.0 contact hours of continuing pharmacy education credit. The ACPE UAN is 0239-0000-12-027-L01. Each pharmacist should claim only those hours of credit that he/she spent in the education activity. SUCCESSFUL COMPLETION STATEMENT Certificates of Completion/Attendance are provided to registered attendees base upon complication of the online evaluation that will be available at http://professional.diabetes.org/sfl through May 21, 2012. For questions regarding continuing education, please contact professionaleducation@diabetes.org. CONTENT VALIDATION STATEMENTS All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients; AND/OR All scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.
Jose Cabral, MD, FACE Program Chair Chair, Department of Endocrinology Medical Director, Diabetes Education Program Cleveland Clinic Florida, Weston, FL Lois Exelbert, RN, MS, CDE, BC-ADM Designated Nurse Planner Administrative Director, Diabetes Care Center Baptist Hospital of Miami, Miami, FL Marcy Galinsky, MD Family Practice Physician - Private Practice, Miami, FL Alan M. Jacobson, BS, RPh Registered Pharmacist, Coral Springs, FL Andrea Meyers Jacobson, RN, BSN, CDE Coordinator Diabetes/Patient Education Joe DiMaggio Children s Hospital - Division of Pediatric Endocrinology Hollywood, FL Jennifer B. Marks, MD Professor of Medicine, Division of Endocrinology, Diabetes & Metabolism Diabetes Research Institute, University of Miami Miller School of Medicine Section Chief, Endocrinology, Diabetes & Metabolism, & Director Diabetes Management Program, Miami VAMC, Miami, FL Della Matheson, RN, CDE Research Coordinator, Type I Diabetes TrialNet Luigi Meneghini, MD, MBA Professor of Clinical Medicine Division of Endocrinology, Diabetes & Metabolism Director, Eleanor & Joseph Kosow Diabetes Treatment Center Diabetes Research Institute Bernardo Obeso, MD University of Miami Miller School of Medicine at Florida Atlantic University Internal Medicine Residency Program JFK Medical Center & West Palm Beach VA Medical Center Graduate Medical Education / Internal Medicine Department Program Director, Internal Medicine Residency Program, Palm Beach, FL Robert S. Oller, DO, CHCQM Chief Executive Officer Division of Clinical Operations Professor of Family Medicine - College of Osteopathic Medicine Nova Southeastern University, Ft. Lauderdale, FL Gary Rothenberg, DPM, CDE, CWS Attending Podiatrist & Director of Resident Training Miami VA Healthcare System, Miami, FL Marile Santamarina, MS, PharmD, CDE Assistant Professor of Pharmacy Practice Palm Beach Atlantic University, Lloyd L. Gregory School of Pharmacy Palm Beach, FL Susan S. Braithwaite, MD, FACP, FACE Visiting Clinical Professor of Medicine University of Illinois-Chicago, Evanston, IL Jose Cabral, MD, FACE Chair, Department of Endocrinology Medical Director, Diabetes Education Program Cleveland Clinic Florida, Weston, FL Alejandro Caicedo, Ph.D. Associate Professor of Medicine Lois Exelbert, RN, MS, CDE, BC-ADM Administrative Director, Diabetes Care Center Baptist Hospital of Miami, Miami, FL Alessia Fornoni, MD, Ph.D. Assistant Professor of Medicine Andrea Meyers Jacobson, RN, BSN, CDE Coordinator Diabetes/Patient Education Joe DiMaggio Children s Hospital - Division of Pediatric Endocrinology Hollywood, FL Atil Y. Kargi, MD Assistant Professor of Medicine Robert F. Kushner, MD, MS, FACP Professor of Medicine Northwestern University Feinberg School of Medicine, Chicago, IL David L. Longworth, MD Chairman, Medical Institute Cleveland Clinic, Cleveland, Ohio Luigi Meneghini, MD, MBA Professor of Clinical Medicine Division of Endocrinology, Diabetes & Metabolism Director, Eleanor & Joseph Kosow Diabetes Treatment Center Diabetes Research Institute Vineeth Mohan, MD Endocrinologist, Cleveland Clinic, Weston, FL Pablo Mora, MD, FACE, CDE Associate Professor of Medicine University of Texas Southwestern Medical Center, Dallas, TX D. Wilkin Parke III, MD Clinical Instructor, Bascom Palmer Eye Institute, Miami, FL Helena W. Rodbard, MD, FACP, MACE Medical Director, Endocrine and Metabolic Consultants, Rockville, MD Kellie Rodriguez, MSN, CDE, CPT Director of Education Services Diabetes Research Institute, University of Miami, Miami, FL Gary Rothenberg, DPM, CDE, CWS Attending Podiatrist & Director of Resident Training Miami VA Healthcare System, Miami, FL Aleida M. Saenz, RN, BSN, CDE Diabetes Educator, Diabetes Research Institute University of Miami School of Medicine, Miami, FL Marile Santamarina, MS, PharmD, CDE Assistant Professor of Pharmacy Practice Palm Beach Atlantic University, Lloyd L. Gregory School of Pharmacy Palm Beach, FL Stacy Smith, MS, RD, LD Registered Dietitian Certified in Child, Adolescent and Adult Weight Management Cleveland Clinic, Weston, FL
DISCLOSURE INFORMATION As an accredited provider of continuing education, it is the Association s policy to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. All participating faculty and planning committee members are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments. Jose M. Cabral, MD, FACE Research Support: Lilly ; AstraZeneca Pharmaceuticals. Speaker s Bureau: Amylin Pharmaceuticals; Boehringer-Ingelheim; Sanofi. Lois Exelbert, RN, MS, CDE, BC-ADM Speaker s Bureau: Merck. Marcy Galinsky, MD Alan M. Jacobson, BS, RPh Andrea Meyers Jacobson, RN, BSN, CDE Jennifer Marks, MD Research Support: Amylin Pharmaceuticals; Lillly; Sanofi. Della Matheson, RN, CDE Advisory Panel: DexCom. Luigi Meneghini, MD, MBA Advisory Panel: Novo Nordisk, Inc.; Sanofi. Consultant: Novo Nordisk, Inc.; Valeritas. Research Support: Boehringer Ingelheim; MannKind; Pfizer, Inc. Stock/Shareholder: DexCom. Bernardo Obeso, MD Robert S. Oller, DO, CHCQM Gary Rothenberg, DPM, CDE, CWS Marile Santamarina, MS, PharmD, CDE Susan S. Braithwaite, MD, FACP, FACE Speaker s Bureau: Lilly; Novo Nordisk, Inc. Jose M. Cabral, MD, FACE Research Support: Lilly; AstraZeneca Pharmaceuticals. Speaker s Bureau: Amylin Pharmaceuticals; Boehringer-Ingelheim; Sanofi. Alejandro Caicedo, Ph.D. Lois Exelbert, RN, MS, CDE, BC-ADM Speaker s Bureau: Merck. Alessia Fornoni, MD, Ph.D. Andrea Meyers Jacobson, RN, BSN, CDE Atil Y. Kargi, MD Speaker s Bureau: Pfizer, Inc. Robert F. Kushner, MD, MS, FACP David L. Longworth, MD Luigi Meneghini, MD, MBA Advisory Panel: Novo Nordisk, Inc.; Sanofi. Consultant: Novo Nordisk, Inc., Valeritas Research Support: Boehringer-Ingelheim; MannKind; Pfizer, Inc. Stock/Shareholder: DexCom. Vineeth Mohan, MD Pablo Mora, MD, FACE, CDE Board Member/Advisory Panel: Novo Nordisk, Inc. Consultant: Novo Nordisk, Inc. Speaker s Bureau: Novo Nordisk, Inc.; Sanofi. D. Wilkin Parke III, MD Helena W. Rodbard, MD, FACP, MACE Board Member/Advisory Panel: Amylin Pharmaceuticals; Novo Nordisk, Inc. Consultant: Amylin Pharmaceuticals; Biodel; Novo Nordisk, Inc.; Roche Diagnostics. Research Support: Amylin Pharmaceuticals; Novo Nordisk, Inc.; Sanofi. Speaker s Bureau: Amylin Pharmaceuticals; Bristol Meyers Squibb; Boehringer-Ingelheim; Lilly; Merck; Novo Nordisk, Inc.; Sanofi. Disclosure of Spouse Consultant: Abbott; Amylin Pharmaceuticals; Geneva Foundation; Halozyme; Lifescan; Merck; Roche Diagnostics; Sanofi. Kellie Rodriguez, MSN, CDE, CPT Gary Rothenberg, DPM, CDE, CWS Aleida M. Saenz, RN, BSN, CDE Consultant: Animas Corporation; Insulet Corporation; Roche Diagnostics; InVentiv Health. Marile Santamarina, MS, PharmD, CDE. Stacy Smith, MS, RD, LD
7:00 a.m. 7:45 a.m. Pre-Function Area ~ Check-In / Name Badge & Information / Exhibits Grand Ballroom C/D ~ Continental Breakfast 7:45 a.m. 8:00 a.m. Grand Ballroom A/B ~ Welcome Chair, Jose Cabral, MD, FACE 8:00 a.m. 9:00 a.m. The Biology of the Human Islet of Langerhans: Recent Progress & It s Implications for the Treatment of Diabetes Alejandro Caicedo, PhD 9:00 a.m. 10:00 a.m. The SHIELD Study & Risk Factors for Onset of Type 2 Diabetes Helena W. Rodbard, MD, FACP, MACE 10:00 a.m. 10:15 a.m. Grand Ballroom C/D ~ Mid-Morning Break 10:15 a.m. 11:15 a.m. Secondary Diabetes Atil Y. Kargi, MD 11:15 a.m. 12:15 p.m. State of the Art: Lifestyle, Pharmacologic & Surgical Therapies for Obesity Robert F. Kushner, MD, MS, FACP 12:15 p.m. 1:30 p.m. Grand Ballroom C/D/G/H ~ Lunch Pre-Function Area ~ Exhibits Presentation Handouts Just as a reminder, in an effort to go green, presentation handouts are located on our website and available for download: http://professional.diabetes.org/sfl Successful Completion Statement Certificates of Completion/Attendance are provided to registered attendees based upon completion of the online evaluation. The online evaluation will be available at http://professional.diabetes.org/sfl through May 21, 2012. For questions regarding continuing education, please email: professionaleducation@diabetes.org.
Grand Ballroom A Grand Ballroom B Meeting Rooms 1 & 2 Meeting Rooms 3 & 4 1:30 p.m. 2:30 p.m. A-1 Continuous Glucose Monitoring: How to Download, Interpret & Utilize the Data Aleida M. Saenz, RN, BSN, CDE B-1 Patient Assistance Program Helping the Underserved & Indigent Marile Santamarina, MS, PharmD, CDE C-1 Wound Care Advances for the 21 st Century Gary Rothenberg, DPM, CDE, CWS D-1 Exercise & Type 1 Diabetes: Evidencebased Practical Management Luigi Meneghini, MD, MBA 2:30 p.m. 3:30 p.m. A-2 Stumped About Pumps? Latest Technologies & Safety in Hospitals Andrea Jacobson, RN, BSN, CDE Lois Exelbert, RN, MS, CDE, BC-ADM B-2 GLP1-based Treatments: How & When to Use them Vineeth Mohan, MD C-2 Retinopathy: Screening & Management D. Wilkin Parke III, MD D-2 Tips & Techniques for Improving Adherence Kellie Rodriguez, MSN, CDE, CPT 3:30 p.m. 3:45 p.m. AFTERNOON BREAK ~ Grand Ballroom C/D 3:45 p.m. 4:45 p.m. A-3 Nutrition Management in Bariatric Surgery Stacy Smith, MS, RD, LD B-3 Intensification of Type 2 Diabetes Medication Pablo Mora, MD, FACE, CDE C-3 Screening & Management of Diabetic Nephropathy Alessia Fornoni, MD, Ph.D. D-3 Team Approach to Diabetes Jose Cabral, MD, FACE Presentation Handouts Just as a reminder, in an effort to go green, presentation handouts are located on our website and available for download: http://professional.diabetes.org/sfl Successful Completion Statement Certificates of Completion/Attendance are provided to registered attendees based upon completion of the online evaluation. The online evaluation will be available at http://professional.diabetes.org/sfl through May 21, 2012. For questions regarding continuing education, please email: professionaleducation@diabetes.org.
7:00 a.m. 7:45 a.m. Pre-Function Area ~ Check-In / Name Badge & Information / Exhibits Grand Ballroom C/D ~ Continental Breakfast 7:45 a.m. 8:00 a.m. Grand Ballroom A/B ~ Welcome Chair, Jose Cabral, MD, FACE 8:00 a.m. 9:00 a.m. The Implications of Healthcare Reform for Endocrinologists David L. Longworth, MD 9:00 a.m. 10:00 a.m. ADA Practical Guideline Review Jose Cabral, MD, FACE 10:00 a.m. 10:15 a.m. Grand Ballroom B ~ Mid-Morning Break 10:15 a.m. 11:15 a.m. When Oral Medications Fail Incretin-Based Therapy or Insulin? Pablo Mora, MD, FACE, CDE 11:15 a.m. 12:15 p.m. Inpatient Diabetes Management Susan S. Braithwaite, MD, FACP, FACE Presentation Handouts Just as a reminder, in an effort to go green, presentation handouts are located on our website and available for download: http://professional.diabetes.org/sfl Successful Completion Statement Certificates of Completion/Attendance are provided to registered attendees based upon completion of the online evaluation. The online evaluation will be available at http://professional.diabetes.org/sfl through May 21, 2012. For questions regarding continuing education, please email: professionaleducation@diabetes.org.
S P E C I A L T H A N K S T O : C O M M E R C I A L S U P P O R T E R S : This activity is supported, in part, by unrestricted educational grants from: Daiichi Sankyo Lilly USA Medtronic Diabetes Merck Novo Nordisk Sanofi E X H I B I T O R S : Amylin Pharmaceuticals Arkray USA BD Medical Diabetes Care Celleration DexCom Greater Miami Association of Diabetes Educators Insulet - OmniPod Lilly USA Medtronic Diabetes Nipro Diagnostics Nova Diabetes Care Novo Nordisk Oraganogenesis Sanofi Santarus Sanvita Spiracur TrialNet US Food & Drug Administration Yucasabe Omissions due to printing deadlines